US clearance for wound debridement device:
This article was originally published in Clinica
Executive Summary
HydroCision has received US FDA 510(k) clearance for its rapid, fluidjet-based wound debridement system. TraumaJet can be used to remove contamination, such as dirt and grease, from a traumatic wound as well as dead or damaged tissue. The system creates its own suction at the site without the need for a connection to an external source and minimises the risk of spreading bacteria or contamination further into a wound said the Andover, Massachusetts-based company. The system will be marketed worldwide by Orthofix International.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.